Godspower Akpomiemie

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 4

Top Topics

Antiretroviral Therapy

Top Venues

British journal of clinical pharmacology

The New England journal of medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Rephaim Mpofu, Aida Nakayiwa Kawuma, Roeland E Wasmann, Godspower Akpomiemie, Nomathemba C Chandiwana, Simiso Mandisa Sokhela, Michelle A Moorhouse, Willem Daniel Francois Venter, Paolo Denti, Lubbe Wiesner, Frank A Post, David W Haas, Gary Maartens, Phumla Z Sinxadi
Determinants of early change in serum creatinine after initiation of dolutegravir-based antiretroviral therapy in South Africa. British journal of clinical pharmacology 90 (5) (2024)
Rephaim Mpofu, Aida Nakayiwa Kawuma, Roeland E Wasmann, Godspower Akpomiemie, Nomathemba C Chandiwana, Simiso Mandisa Sokhela, Michelle A Moorhouse, Willem Daniel Francois Venter, Paolo Denti, Lubbe Wiesner, Frank A Post, David W Haas, Gary Maartens, Phumla Z Sinxadi
Determinants of early change in serum creatinine after initiation of dolutegravir-based antiretroviral therapy in South Africa. British journal of clinical pharmacology 90 (5) (2024)
Rephaim Mpofu, Aida Nakayiwa Kawuma, Roeland E Wasmann, Godspower Akpomiemie, Nomathemba C Chandiwana, Simiso Mandisa Sokhela, Michelle A Moorhouse, Willem Daniel Francois Venter, Paolo Denti, Lubbe Wiesner, Frank A Post, David W Haas, Gary Maartens, Phumla Z Sinxadi
Determinants of early change in serum creatinine after initiation of dolutegravir-based antiretroviral therapy in South Africa. British journal of clinical pharmacology (2024)
Willem Daniel Francois Venter, Michelle A Moorhouse, Simiso Mandisa Sokhela, Lee Fairlie, Nonkululeko Mashabane, Masebole Masenya, Celicia M Serenata, Godspower Akpomiemie, Ambar Qavi, Nomathemba C Chandiwana, Shane A Norris, Matthew Francis Chersich, Polly Clayden, Elaine J Abrams, Natasha Arulappan, Alinda G Vos-Seda, Kaitlyn McCann, Bryony Simmons, Andrew Hill
Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV. The New England journal of medicine 381 (9) (2019)